SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-002256
Filing Date
2018-08-10
Accepted
2018-08-10 16:31:20
Documents
44
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_10q-063018.htm 10-Q 244764
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 8474
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 8766
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 3986
  Complete submission text file 0001683168-18-002256.txt   1413795

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20180630.xml EX-101.INS 173197
6 XBRL SCHEMA FILE xbio-20180630.xsd EX-101.SCH 19197
7 XBRL CALCULATION FILE xbio-20180630_cal.xml EX-101.CAL 31784
8 XBRL DEFINITION FILE xbio-20180630_def.xml EX-101.DEF 70550
9 XBRL LABEL FILE xbio-20180630_lab.xml EX-101.LAB 132508
10 XBRL PRESENTATION FILE xbio-20180630_pre.xml EX-101.PRE 110147
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 181009250
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1